Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation: The ULTIMATE Trial

• Published in: Journal of the American College of Cardiology 2018-12, Vol.72 (24), p.3126-3137
• Main Authors: Zhang, Junjie, Gao, Xiaofei, Kan, Jing, Ge, Zhen, Han, Leng, Lu, Shu, Tian, Nailiang, Lin, Song, Lu, Qinghua, Wu, Xueming, Li, Qihua, Liu, Zhizhong, Chen, Yan, Qian, Xuesong, Wang, Juan, Chai, Dayang, Chen, Chonghao, Li, Xiaolong, Gogas, Bill D, Pan, Tao, Shan, Shoujie, Ye, Fei, Chen, Shao-Liang
• Format: Article
• Language: English
• Subjects: Angiography; Cardiology; Cardiovascular disease; Clinical outcomes; Confidence intervals; Coronary vessels; Drug delivery; Heart attacks; Implantation; Implants; Lesions; Medical imaging; Myocardial infarction; Patients; Stents; Surgical implants; Thromboembolism; Thrombosis; Ultrasonic imaging; Ultrasound
• ISSN: 0735-1097; 1558-3597
• DOI: 10.1016/j.jacc.2018.09.013

Intravascular ultrasound (IVUS)-guided drug-eluting stent (DES) implantation is associated with fewer major adverse cardiovascular events compared with angiography guidance for patients with individual lesion subset. However, the beneficial effect on major adverse cardiovascular event outcome of IVUS guidance over angiography guidance in all-comers who undergo DES implantation still remains understudied. This study aimed to determine the benefits of IVUS guidance over angiography guidance during DES implantation in all-comer patients. A total of 1,448 all-comer patients who required DES implantation were randomly assigned (1:1 ratio) to either an IVUS guidance or angiography guidance group. The primary endpoint was target-vessel failure (TVF) at 12 months, including cardiac death, target-vessel myocardial infarction, and clinically driven target-vessel revascularization (TVR). The procedure was defined as a success if all IVUS-defined optimal criteria were met. At 12 months follow-up, 60 TVFs (4.2%) occurred, with 21 (2.9%) in the IVUS group and 39 (5.4%) in the angiography group (hazard ratio [HR]: 0.530; 95% confidence interval [CI]: 0.312 to 0.901; p = 0.019). In the IVUS group, TVF was recorded in 1.6% of patients with successful procedures, compared with 4.4% in patients who failed to achieve all optimal criteria (HR: 0.349; 95% CI: 0.135 to 0.898; p = 0.029). The significant reduction of clinically driven target-lesion revascularization or definite stent thrombosis (HR: 0.407; 95% CI: 0.188 to 0.880; p = 0.018) based on lesion-level analysis by IVUS guidance was not achieved when the patient-level analysis was performed. The present study demonstrates that IVUS-guided DES implantation significantly improved clinical outcome in all-comers, particularly for patients who had an IVUS-defined optimal procedure, compared with angiography guidance. (Intravascular Ultrasound Guided Drug Eluting Stents Implantation in "All-Comers" Coronary Lesions [ULTIMATE]; NCT02215915).